Dermatology · Coral Springs, FL
NPI
1861459497
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3000 N University Dr, Suite K
Coral Springs, FL, 33065
Phone (954) 752-2630
Groups this clinician bills Medicare through
Medicare paid, 2024
$502K
11,373 services
Medicare patients, 2024
1,619
Average age 75
Drug cost, 2024
$343K
4,162 prescriptions
Company payments, 2025
$1,636
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barry A Sarkell was code 17003 (destruction skin lesion), 3,872 times for 621 patients. In total Barry A Sarkell billed 11,373 services in 55 codes, and Medicare paid $502K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,872 | 621 | $4.97 | $19K |
| 99213 Office E&M - Established | Office | 2,223 | 1,194 | $64.35 | $143K |
| 17000 Destruction Skin Lesion | Office | 1,337 | 820 | $38.33 | $51K |
| 11102 Skin Biopsy | Office | 1,019 | 737 | $72.71 | $74K |
| 99214 Office E&M - Established | Office | 815 | 561 | $90.77 | $74K |
| 11103 Skin Biopsy | Office | 390 | 238 | $39.78 | $16K |
| 17261 Destruction Skin Lesion | Office | 158 | 119 | $96.12 | $15K |
| 17262 Destruction Skin Lesion | Office | 134 | 108 | $121.88 | $16K |
| 99212 Office E&M - Established | Office | 131 | 125 | $41.59 | $5,449 |
| 17004 Destruction Skin Lesion | Office | 111 | 66 | $129.88 | $14K |
| 99203 Office E&M - New | Office | 103 | 103 | $71.97 | $7,413 |
| 17110 Destruction Skin Lesion | Office | 94 | 83 | $80.79 | $7,594 |
| 17281 Destruction Skin Lesion | Office | 71 | 60 | $133.95 | $9,510 |
| 99204 Office E&M - New | Office | 49 | 49 | $109.34 | $5,358 |
| 69100 Other Organ Systems | Office | 36 | 34 | $54.11 | $1,948 |
By year: 2022 $418K for 10,969 services; 2023 $509K for 13,310 services; 2024 $502K for 11,373 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| Q0112 All potassium hydroxide (koh) preparations | 15 | 12 | $5.71 | $85.65 |
Medicare prescription drug claims, 2024
In 2024, the drug Barry A Sarkell prescribed most often to Medicare patients was Ketoconazole, with 989 prescriptions and refills. In total Barry A Sarkell wrote 4,162 Medicare prescriptions that cost $343K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 989 | 1,044 | 404 | $16K |
| Hydrocortisone Generic | 694 | 722 | 358 | $4,292 |
| Triamcinolone Acetonide Generic | 584 | 629 | 367 | $6,413 |
| Mupirocin Generic | 213 | 217 | 151 | $1,488 |
| Hydroxyzine Hcl Generic | 190 | 236 | 84 | $1,889 |
| Clindamycin Phosphate Generic | 184 | 189 | 95 | $6,045 |
| Betamethasone Dipropionate Generic | 183 | 186 | 100 | $8,042 |
| Fluocinonide Generic | 137 | 156 | 55 | $6,058 |
| Ciclopirox Ciclopirox Olamine | 98 | 112 | 56 | $4,512 |
| Clobetasol Propionate Generic | 87 | 96 | 48 | $5,095 |
| Cephalexin Generic | 76 | 76 | 68 | $338 |
| Doxycycline Hyclate Generic | 73 | 97 | 35 | $1,603 |
| Metronidazole Generic | 60 | 61 | 40 | $2,288 |
| Valacyclovir Valacyclovir Hcl | 57 | 91 | 25 | $1,760 |
| Doxycycline Monohydrate Generic | 52 | 53 | 22 | $1,127 |
Brand drugs: 106 claims; generic drugs: 4,056 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barry A Sarkell $1,636 ($1,636 in general payments such as food, travel and fees) from 16 companies. The largest payer was Galderma Laboratories, L.P. with $326.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 12 | $326 |
| Abbvie Inc. ABBV | 20 | $273 |
| Genzyme Corporation SNY | 7 | $214 |
| Janssen Biotech, Inc. JNJ | 11 | $200 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $120 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $97.36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71.68 |
| UCB, Inc. UCB.BR | 2 | $59.69 |
| Amgen Inc. AMGN | 2 | $48.56 |
| Pfizer Inc. PFE | 2 | $47.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.